Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
The standard dosing schedule starts at 2.5 mg weekly and escalates every four weeks: Weeks 14: 2.5 mg weekly (initiation dose to acclimate to GLP-1/GIP receptor activation) Weeks 58: 5 mg weekly Weeks 912: 7.5 mg weekly (optional intermediate step) Weeks 1316: 10 mg weekly Weeks 1720: 12.5 mg weekly (optional intermediate step) Week 21 onward: 15 mg weekly (maximum maintenance dose) Tirzepatide is injected subcutaneously just under the skin using a pre-filled pen or syringe
Diabetic neuropathy Peripheral neuropathy Up to 50% of diabetic patients develop peripheral neuropathy, a type of nerve damage that may result in pain, loss of sensation, and weakness, particularly in the lower extremities (67)
The baseline prevalence of individuals meeting criteria of metabolic syndrome were somewhat larger in women and seems to be driven mainly by the waist circumference criteria
The peptides selectivity for adipose tissue without muscle protein breakdown distinguishes it from non-specific weight loss approaches
Beverage Selection : Water remains the optimal choice for hydration
